These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25807335)

  • 1. Interleukin-23 in the pathogenesis and treatment of psoriasis.
    Kollipara R; Downing C; Gordon R; Tyring S
    Skin Therapy Lett; 2015; 20(2):1-4. PubMed ID: 25807335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating the Science of Psoriasis.
    Gordon KB
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S64. PubMed ID: 27526392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
    Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
    Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
    Katayama H
    Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines.
    Fitch E; Harper E; Skorcheva I; Kurtz SE; Blauvelt A
    Curr Rheumatol Rep; 2007 Dec; 9(6):461-7. PubMed ID: 18177599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and early clinical data on IL-17 blockade in psoriasis.
    Nwe SM; Champlain AH; Gordon KB
    Expert Rev Clin Immunol; 2013 Jul; 9(7):677-82. PubMed ID: 23899238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ustekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primer.
    Quatresooz P; Hermanns-Lê T; Piérard GE; Humbert P; Delvenne P; Piérard-Franchimont C
    J Biomed Biotechnol; 2012; 2012():147413. PubMed ID: 22754278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IL-17 in psoriasis.
    Malakouti M; Brown GE; Wang E; Koo J; Levin EC
    J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?
    Chiricozzi A; Saraceno R; Chimenti MS; Guttman-Yassky E; Krueger JG
    Expert Opin Ther Targets; 2014 May; 18(5):513-25. PubMed ID: 24568095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular sources of IL-17 in psoriasis: a paradigm shift?
    Keijsers RR; Joosten I; van Erp PE; Koenen HJ; van de Kerkhof PC
    Exp Dermatol; 2014 Nov; 23(11):799-803. PubMed ID: 25039885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.
    Lowes MA; Russell CB; Martin DA; Towne JE; Krueger JG
    Trends Immunol; 2013 Apr; 34(4):174-81. PubMed ID: 23291100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
    Nakajima K
    J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of cells and cytokines in the pathogenesis of psoriasis.
    Coimbra S; Figueiredo A; Castro E; Rocha-Pereira P; Santos-Silva A
    Int J Dermatol; 2012 Apr; 51(4):389-95; quiz 395-8. PubMed ID: 22435425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [IL-23 and Th17 cells in infections and psoriasis].
    Kagami S
    Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):13-9. PubMed ID: 21372509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders.
    Gooderham MJ; Papp KA; Lynde CW
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1111-1119. PubMed ID: 29438576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
    Mease PJ
    Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Th17 pathway in psoriasis.
    Elloso MM; Gomez-Angelats M; Fourie AM
    J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of IL-23 and the IL-23/T
    Girolomoni G; Strohal R; Puig L; Bachelez H; Barker J; Boehncke WH; Prinz JC
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1616-1626. PubMed ID: 28653490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.